Form D · Business Services
Formulary Insights, LLC
Indianapolis, IN · CIK 0001876144
Offering snapshot reported Aug 2, 2021 · SEC filing
- Reported sold
- $1.7M Offering amount: $2M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2021 | Initial | $1,700,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-408418
Source: Form D, filed Aug 2, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dan Briggs | Director |
| Amy R. Heath | Director |
| Peter Vaccaro | Director |
Issuer details
Industry: Business Services (See others in industry)
Address:
One Indiana Square, Suite 3500
Indianapolis, IN, 46204
Indianapolis, IN, 46204